文献速递腹部CT

平扫CT移植肝低衰减与肝移植后1个月死亡或移植物功能衰竭相关

Low Graft Attenuation at Unenhanced CT: Association with 1-Month Mortality or Graft Failure after Liver Transplantation.
PubMed 文献 · Radiology · 2017-12-21

研究纳入663例肝移植受者,于移植后7天内行平扫CT,由两名放射科医师盲法独立评估移植肝衰减(低于脾脏为低衰减)。原发性早期肝功能不全组中,低衰减者1个月死亡或移植物功能衰竭的阳性预测值为46.7%、阴性预测值100%、敏感度100%、特异度89.0%、准确率90.0%,高或等衰减者无1个月死亡或移植物功能衰竭(P < .001)。

要点

  • 移植肝平扫CT衰减低于脾脏时,在原发性早期肝功能不全受者中与1个月死亡或移植物功能衰竭相关。
  • 原发性早期肝功能不全组中,低衰减者1个月死亡或移植物功能衰竭阳性预测值46.7%,阴性预测值100%。
  • 继发性早期肝功能不全组中,移植肝衰减与1个月死亡或移植物功能衰竭无显著关联(P = .181)。

核心结论

  • 在原发性早期肝功能不全的肝移植受者中,平扫CT移植肝低衰减可能与1个月死亡或移植物功能衰竭相关。

研究设计与样本

  • 研究纳入2014年12月至2016年8月间663例肝移植后7天内行CT检查的受者;两名放射科医师盲法回顾性独立评估平扫CT移植肝衰减(高或等衰减为移植肝衰减大于或等于脾脏,低衰减为移植肝衰减小于脾脏);以移植后7天内实验室指标组合诊断早期肝功能不全并分为原发性和继发性。

关键影像表现/征象

  • 平扫CT上移植肝衰减低于脾脏定义为低衰减,高于或等于脾脏定义为高或等衰减。
  • 低衰减在早期肝功能不全患者中比功能正常患者更常见(P < .001)。

诊断标准与关键数值

  • 原发性早期肝功能不全组中,低衰减预测1个月死亡或移植物功能衰竭的阳性预测值为46.7%、阴性预测值为100%、敏感度为100%、特异度为89.0%、准确率为90.0%。
  • 原发性早期肝功能不全组中,15例低衰减患者有7例在1个月内死亡或移植物功能衰竭,高或等衰减者无1个月死亡或移植物功能衰竭(P < .001)。
  • 继发性早期肝功能不全组中,移植肝衰减与1个月死亡或移植物功能衰竭无显著关联(P = .181)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate whether low graft attenuation at unenhanced computed tomography (CT) is associated with 1-month mortality or graft failure after liver transplant and determine its diagnostic performance. Materials and Methods Included were 663 recipients who underwent CT imaging within 7 days after liver transplant between December 2014 and August 2016. Initial poor function (IPF) was diagnosed by using a combination of laboratory values within 7 days after liver transplant and subdivided patients into primary and secondary IPF. At 1 month after the operation, mortality and graft failure or survival in recipients was categorized. Two radiologists who were blinded to clinical data retrospectively and independently evaluated graft attenuation on unenhanced CT images (high or isoattenuation, graft attenuation greater than or equal to that of spleen; low, graft attenuation less than that of spleen). The interobserver agreement was evaluated by using intraclass correlation coefficient and κ statics. Incidence of low graft attenuation between recipients with IPF and those with normal function was compared by using χ2 test. The relationship between graft attenuation and outcome in primary and secondary IPF was evaluated by using log-rank test. Results Of 663 recipients, 114 had IPF (80 primary; 34 secondary). After 1 month, 11 had graft failure or died, whereas 652 survived. Low graft attenuation was more common in patients with IPF than in normal-function patients (P < .001). In the primary group (those without identifiable cause), 15 patients had low graft attenuation, which led to mortality or graft failure within 1 month in seven of those patients. No recipient with high or isoattenuation had 1-month mortality or graft failure (P < .001). The secondary group (those with identifiable cause) showed no significant association between graft attenuation and 1-month mortality and graft failure (P = .181). Values of low graft attenuation for 1-month mortality and graft failure in primary IPF were positive predictive value, 46.7%; negative predictive value, 100%; sensitivity, 100%; specificity, 89.0%; and accuracy, 90.0%. There was excellent interobserver agreement in the assessment of graft attenuation (intraclass correlation coefficient, 0.957; κ = 1.00). Conclusion Low graft attenuation can be associated with 1-month mortality or graft failure in liver graft recipients with primary IPF. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim JS, Kwon JH, Kim KW, et al. Low Graft Attenuation at Unenhanced CT: Association with 1-Month Mortality or Graft Failure after Liver Transplantation. Radiology. 2017. PMID: 29267144. doi:10.1148/radiol.2017171144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。